Arepalli, C. and Palani, R. 2026. Low-Dose Alemtuzumab-Based Induction in Kidney Transplantation: A Retrospective Comparison of Maintenance Immunosuppression, Long-Term Graft Outcomes, and Induction Costs. Adolescência e Saúde. (Oct. 2026), 2735–2739.